BCP and Terpenes: A Breakthrough in Inflammation Control

Inflammation plays a crucial role in the body’s defense system, but when it becomes chronic, it can lead to severe health problems. Scientists are now exploring plant-based solutions for inflammation management, and β-caryophyllene inflammation reduction has gained particular attention.

β-caryophyllene acts as a selective CB2 receptor agonist, meaning it binds to these receptors to help regulate immune responses and inflammation. This makes it a promising candidate for treating inflammatory conditions like arthritis, colitis, and cardiovascular diseases.

Aside from β-caryophyllene, several terpenes that help with inflammation are being investigated for their therapeutic potential. For example, myrcene, found in mangoes and thyme, has been shown to reduce pain and swelling in laboratory studies. Similarly, bisabolol, a major compound in chamomile, exhibits soothing effects on skin inflammation and wound healing.